Cargando…
ANXA10 is a prognostic biomarker and suppressor of hepatocellular carcinoma: a bioinformatics analysis and experimental validation
Liver hepatocellular carcinoma (LIHC) is one of the main cancers worldwide and has high morbidity and mortality rates. Although previous studies have shown that ANXA10 is expressed at low levels in LIHC tumor tissues, the biological function of ANXA10 in LIHC is still unclear. Therefore, we utilized...
Autores principales: | Zhang, Chaohua, Peng, Linglong, Gu, Haitao, Wang, Jijian, Wang, Yaxu, Xu, Zhiquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884230/ https://www.ncbi.nlm.nih.gov/pubmed/36709331 http://dx.doi.org/10.1038/s41598-023-28527-x |
Ejemplares similares
-
Adherence to diabetes risk reduction diet and the risk of head and neck cancer: a prospective study of 101,755 American adults
por: Wu, Xia, et al.
Publicado: (2023) -
Bioinformatic Analysis of Immune Significance of RYR2 Mutation in Breast Cancer
por: Xu, Zhiquan, et al.
Publicado: (2021) -
Comprehensive Analysis of the Immune Implication of AKAP12 in Stomach Adenocarcinoma
por: Xu, Zhiquan, et al.
Publicado: (2022) -
Case report: A case report and literature review of extrapancreatic solid pseudopapillary neoplasm
por: Liu, Hang, et al.
Publicado: (2022) -
ANXA1 as a Prognostic and Immune Microenvironmental Marker for Gliomas Based on Transcriptomic Analysis and Experimental Validation
por: Lin, Zhongxiao, et al.
Publicado: (2021)